Skip to content

Comparison of ciprofol versus remimazolam for painless bronchoscopy

Comparison of ciprofol versus remimazolam for painless bronchoscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092527
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-11-20
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless fiberoptic bronchoscopy (PFB) patients

Interventions

C:Induction of anesthesia with ciprofol and sufentanil
R:Induction of anesthesia with remazolam and sufentanil

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Gender is not limited, age >= 18 years old; 2. Subjects who plan to undergo bronchoscopy under laryngeal mask ventilation; 3. ASA grade is I-III; 4. Able to understand and voluntarily sign an informed consent form (ICF), willing to comply with and expected to complete the test according to the requirements of the test protocol.

Exclusion criteria

Exclusion criteria: 1. patients with contrain dications to deep sedation/general anaesthesia or a previous history of sedation/anaesthesia accidents; 2. patients with known allergy to eggs, soya products or test drugs (cyclobenzaprine, sufentanil or remazolam); 3. patients in the presence of a difficult airway; 4. patients in the presence of bradycardia or other severe cardiovascular disease; 5. patients with severe injury or disease of vital organs such as lungs, brain, liver or kidneys; 6. patients with long-term use of sedatives or antidepressants; 7. pregnant or breastfeeding women; 8. patients who are unable to communicate or co-operate; 9. patients with myasthenia gravis

Design outcomes

Primary

MeasureTime frame
Sedation success rate;

Secondary

MeasureTime frame
Vital signs;The number and dosage of drug refills;perioperative adverse events;Patient satisfaction;

Countries

China

Contacts

Public ContactZhou Lin

The First Affiliated Hospital of University of Science and Technology of China

13866702756@163.com+86 138 6670 2756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026